DIAGNOSTIC TECHNIQUE FOR FATTY HEPATOSIS Russian patent published in 2016 - IPC A61B5/00 A61B6/00 

Abstract RU 2578080 C2

FIELD: medicine.

SUBSTANCE: body weight index (BWI) is calculated. A radioisotope preparation is administered parenterally. Above a projection of the liver, γ-particle count is measured over a period of time until the statistical maximum is reached. A time from the beginning of the study to the moment of reaching the maximum threshold γ-particle accumulation (Tmax) is determined. A hepatocyte functional activity index (HFAI) is determined by the claimed formula. The HFAI value is used to state the hepatic health. If the HFAI ranges from 0 to 9.9, the normal functional activity of hepatocytes is stated. If the HFAI is from 10 to 19.9, the risk of functional disorders is observed. Reversible functional disorders of hepatocytes (fatty hepatosis) is stated if the HFAI is from 20 to 29.9. The HFAI of more than 30 states that the patient suffers from irreversible organic hepatic disorders (steatohepatitis, cirrhosis). If the HFAI has a negative value, the extrahepatic factors, such as diseases increasing cellular metabolism (thyrotoxicosis), pre-study medication in disregard for the instructions are said to have an effect.

EFFECT: technique enables the quantitative and simple assessment of the current hepatic health, makes it possible to determine if the functional disorders are reversible, and how intensive they manifest, ensures the assessment of predicting the clinical course of the disease and the efficacy of rehabilitation measures, by the fact that the diagnostic procedure involves the most optimal parameters.

3 cl, 1 dwg, 2 ex

Similar patents RU2578080C2

Title Year Author Number
METHOD OF EARLY DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE 2022
  • Tsyganova Yuliya Vadimovna
  • Tarasova Larisa Vladimirovna
  • Diomidova Valentina Nikolaevna
  • Lazebnik Leonid Borisovich
RU2798723C1
METHOD OF SCREENING STUDY OF RISK OF DEVELOPING LIVER DAMAGE OF DIFFERENT ORIGINS 2017
  • Shipovskaya Anastasiya Andreevna
  • Dudanova Olga Petrovna
RU2675015C1
METHOD FOR DETERMINING AND CALCULATING THE NECESSARY REQUIRED INSULIN DOSE FOR TYPE SECONDARY DIABETES AND FORMED INSULIN DEPENDENCE 2018
  • Kurnikova Irina Alekseevna
  • Ualikhanova Ajgerim
RU2684393C1
METHOD FOR EVALUATION OF FUNCTIONAL RESERVES OF BODY 2007
  • Kurnikova Irina Alekseevna
RU2342900C1
KURNIKOVA'S METHOD OF DEFINING BIOLOGICAL COMPONENT OF REHABILITATION POTENTIAL FOR DIABETES PATIENTS 2007
  • Kurnikova Irina Alekseevna
RU2344751C1
METHOD OF DIAGNOSING DEGREE OF EXPRESSION OF FATTY HEPATOSIS IN PEOPLE WITH DIABETES MELLITUS 2012
  • Vorob'Ev Sergej Vladislavovich
  • Kuz'Menko Natalija Aleksandrovna
RU2495626C1
METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE 2023
  • Ufimtseva Irina Vladimirovna
  • Pirogova Irina Yurevna
RU2813033C1
METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES 2020
  • Bakulin Igor Gennadevich
  • Abatsieva Madina Petrovna
  • Vakhitov Timur Yasherovich
  • Sitkin Stanislav Igorevich
  • Demyanova Elena Valerevna
RU2744021C1
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME 2018
  • Alekseeva Natalya Sergeevna
  • Selezneva Evgeniya Yurevna
RU2686042C1
METHOD FOR PREDICTION OF PROGRESSIVE CLINICAL COURSE OF EARLY FORMS OF NON-ALCOHOLIC FATTY LIVER DISEASE 2020
  • Shipovskaya Anastasiya Andreevna
  • Dudanova Olga Petrovna
  • Larina Nadezhda Alekseevna
  • Kurbatova Irina Valerevna
RU2768466C1

RU 2 578 080 C2

Authors

Kurnikova Irina Alekseevna

Akhmadullina Guzjal Ilgisovna

Babin Sergej Nikolaevich

Evstjagina Kira Aleksandrovna

Dates

2016-03-20Published

2014-12-19Filed